Viewing nowCombinationRosucande Tablets 10/8 milligrams
Rosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Gunil Biopharm Co., Ltd.

MFDS item code 202107118 · Approved 2021.10.25 · Insurance code 073000720
Improvement of lipid abnormalities; treatment of hypertension and heart failure; inhibition of atherosclerosis progression and cardiovascular risk
This medication is used for patients who require simultaneous administration of two medications: Candesartan Cilexetil and Rosuvastatin. Candesartan Cilexetil is used for the treatment of essential hypertension and in heart failure patients with impaired left ventricular function when additional ACE inhibitors are needed or are not well tolerated. Rosuvastatin is used as an adjunct to diet in various lipid disorder diseases, including hypercholesterolemia, familial hypercholesterolemia, and dysbetalipoproteinemia, and helps reduce the risks of stroke, myocardial infarction, and vascular revascularization in high-risk cardiovascular disease patients. The combination of the two medications allows for effective management of hypertension and dyslipidemia, used for the prevention and treatment of cardiovascular diseases.
This medicine is for use in adults only. The dose should be individualized for each patient based on the effects and tolerability of each ingredient, candesartan cilexetil and rosuvastatin. ○ Candesartan cilexetil 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatment should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: Administer an initial dose of 4 mg with careful caution in patients at high risk of hypotension, such as those with volume depletion. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those on hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks and increased to a maximum of 32 mg once daily, taking the patient's tolerability into account. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted as a maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased to a maximum of 20 milligrams daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients. Patients taking candesartan cilexetil and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience of administration.
Essential hypertension: The safety and efficacy in adolescents and children aged 18 years or younger have not been established. Heart failure: The safety and efficacy in adolescents and children aged 18 years or younger have not been established.
This medication can cause serious harm to the fetus when taken during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It should not be used in patients with allergic reactions to this drug, severely impaired liver function, pregnant or breastfeeding women, and patients with certain muscle diseases. Special caution should be taken when using this drug in the elderly, patients with liver insufficiency, those with hyperkalemia, or those with impaired kidney function, with regular blood tests and monitoring required. If symptoms such as muscle pain or weakness occur, consult a physician immediately, and if muscle-related blood test values significantly increase with these symptoms, the medication should be discontinued. This medication may affect liver function, so liver enzyme levels should be checked periodically before and during treatment; report any symptoms of liver dysfunction to a doctor immediately. Interactions may occur when used with other medications, so inform your doctor or pharmacist of any other medications you are taking. Women of childbearing potential should use appropriate contraception, and it is safer not to use this medication during pregnancy or breastfeeding. In the case of overdose, appropriate treatment is needed depending on the symptoms, and this drug is not removed by dialysis, so caution is warranted. Be careful as dizziness or fatigue may occur when driving or operating machinery. Keep out of reach of children and do not transfer medicines to other containers.
Headache, nasopharyngitis, local infection, fatigue, generalized pruritus, dermatitis, itching, joint stiffness, limb pain, photophobia, dyspepsia, elevated blood sugar, decreased serum sodium, hand fracture, hypoglycemia, nephrolithiasis, cough, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, constipation, nausea, abdominal pain, pancreatitis, rash, arthralgia, lower back pain, muscle cramps, gout, erectile dysfunction, dizziness, positional vertigo, chalazion, periodontitis, inflammation, foreign body sensation, cataract, elevated blood sugar, decreased serum sodium, hand fracture, hypoglycemia, nephrolithiasis, cough, tooth extraction, syncope, generalized pain, sensory abnormalities, chest discomfort, anorexia, abdominal distension, abnormal liver function tests, edema, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, eosinophilia with accompanying systemic symptoms drug reaction syndrome, lupus-like syndrome, immune-mediated necrotizing myopathy, amnesia, peripheral neuropathy, dyspnea, diarrhea, polyneuropathy, sleep disorders, decreased libido, forgetfulness, anorexia, increased appetite, tinnitus, dysgeusia, erectile dysfunction, angioedema, hypotension, hyperkalemia, renal impairment, increased creatinine, increased urea, increased potassium, elevated ALT, elevated AST, elevated γ-GTP, liver dysfunction, jaundice, increased blood pressure, cerebral infarction, spondyloarthritis myelopathy, musculoskeletal discomfort, pneumonia, femoral fracture, contusion, unstable angina, idiopathic pulmonary fibrosis, moist cough, worsening hypertension, unstable blood pressure, vertigo, positional vertigo, adrenal insufficiency, asthenia, fever, perceptual abnormalities, anxiety, depression, somnolence, dyspnea, rash, increased sweating, hematuria, intestinal vascular edema, diarrhea, hepatitis, interstitial pneumonia, shock, syncope, loss of consciousness, blood and lymphatic system abnormalities, leukopenia, neutropenia, agranulocytosis, hyponatremia, hypoglycemia, thrombocytopenia, liver failure, severe muscle weakness, ocular myasthenia, myositis, myopathy, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to protect it from air and moisture. It is recommended to maintain the storage temperature between 1 and 30 degrees Celsius.
Pink, round, film-coated tablet
30 tablets/box [10 tablets/PTP x 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Gunil Biopharm Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
AlboGen Korea Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Candesartan Cilexetil 32mg
Tablet · Prescription medication · Combination
Albogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Alvogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Alvogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.